The aging woman: The role of medical therapy

International Journal of Gynecology and Obstetrics

Volumn 82, Issue 3, 2003, Pages 381-391

  Wilken Jensen, C ^a   Ottesen, B ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

Alternative therapies; HRT; Menopause

Indexed keywords

ESTROGEN; GESTAGEN;

AGING; ALTERNATIVE MEDICINE; BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; CHINESE MEDICINE; CLINICAL TRIAL; COLORECTAL CANCER; DEMOGRAPHY; DEVELOPED COUNTRY; DIET SUPPLEMENTATION; DISABILITY; DRUG EFFICACY; ENDOMETRIUM CANCER; EVIDENCE BASED MEDICINE; FEMALE; FRAGILITY FRACTURE; FUNCTIONAL DISEASE; HEALTH CARE; HEALTH CARE NEED; HEALTH PRACTITIONER; HEALTH PROGRAM; HEART PROTECTION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; ISCHEMIC HEART DISEASE; LIFESPAN; MEDICAL DOCUMENTATION; MENOPAUSAL SYNDROME; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SOCIAL STATUS; UROGENITAL TRACT DISEASE; VAGINA BLEEDING;

EID: 0141429174     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(03)00223-6     Document Type: Article

References (26)

1. Speroff L., Glass R.H., Kase N.G. Clinical Gynecologic endocrinology and infertility. 1999;644-724 Lippincott Williams and Wilkins, Baltimore.
2. Pedersen A.T., Lidegaard Ø., Kreiner S., Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet. 350:1997;1277-1283.
3. Keatin N.L., Cleary P.D., Rossi A.S., Zaslavsky A.M., Ayanian J.Z. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 130:1999;545-553.
4. World Population Ageing 1950-2050. 2002;29-32 Population Division, DESA, United Nations.
5. UNFPA Annual Report 2002, http://www.unfpa.org.
6. Wiener J.M., Tilly J. Population ageing in the United States of America: implications for public programmes. Int J Epidemiol. 31:2002;776-781.
7. Evans J.G. The gifts reserved for age. Int J Epidemiol. 31:2002;792-795.
8. Fraenkel L. Die Funktion des Corpus Luteum. Arch Gynäkol. 68:1903;438-497.
9. Bishop P.M.F. A clinical experiment in oestrin therapy. Br Med J. 1:1938;939.
10. Wilson R.A., Wilson Th.A. The fate of the non-treated postmenopausal woman: a plea for the maintenance of adequate estrogen from puberty to the grave. J Am Geriatr Soc. 34:(11):1963;7.
11. Speroff L., Glass R.H., Kase N.G. Clinical gynecologic endocrinology and infertility. 1999;725-767 Lippincott Williams and Wilkins, Baltimore.
12. Burkman R.T., Collins J.A., Greene R.A. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol. 185:2001;13-23.
13. Grodstein F., Stampfer M.J., Goldhaber S.Z., Manson J.E., Colditz G.A., Speizer F.E., et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet. 348:1996;983-987.
14. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc. 288:2002;321-333.
15. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc. 380:1998;605-613.
16. Hulley S., Furberg C., Barrett-Connor E., Cauley J., Grady D., Haskell W., et al. Non-cardiovascular disease outcomes during 6.8 years of hormone therapy. J Am Med Assoc. 288:2002;58-66.
17. Grady D., Herrington D., Bittner V., Blumienthal R., Davidson M., Hlatky M., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. J Am Med Assoc. 288:2002;49-57.
18. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., Allan J.D. Postmenopausal hormone replacement therapy, scientific review. J Am Med Assoc. 288:2002;872-881.
19. Rødstrøm K., Bengtsson C., Lissner L., Årkelund C. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden. Br Med J. 319:1999;890-893.
20. Hundrup Y.A., Obel E.B., Rasmussen N.K., Philip J. Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand. 79:2000;194-201.
21. Hundrup Y.A., Thoning H., Obel E.B., Rasmussen N.K., Philip J. Lifestyle factors and choice of hormone replacement therapy among Danish nurses. Scand J Public Health. 30:(1):2002;47-53.
22. Løkkegaard E., Pedersen A.T., Heitmann B.L., Jovanovic Z., Keding N., Hundrup Y.A., et al. Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study. Br Med J. 22:2003;426-431.
23. Løkkegaard E, Jovanovic Z, Heitmann BL, Keding N, Ottesen B, Hundrup YA, et al. Increased risk of stroke in hypertensive women using hormone replacement therapy. Analyses based on the Danish Nurse Cohort Study. Arch Neurol, in press.
24. Warren M.P., Shortle B., Dominguez J.E. Use of alternative therapies in menopause. Best Pract Res Clin Obstet Gynaecol. 16:2002;411-448.
25. Kang H.J., Ansbacher R., Hammoud M.M. Use of alternative and complementary medicine in menopause. Int J Gynecol Obstet. 79:2002;195-207.
26. Kessler R.C., Davis R.B., Foster D.F., Van Rompay M.I., Walters E.E., Wilkey S.A., et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 135:(4):2001;262-268.